RR
67
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Rogier Rooswinkel.
Investment Thesis & Strategy
Forbion invests in various stages of biotech and health & hospital services companies, seeking to support innovative and impactful ventures in the healthcare sector.
Portfolio Companies
Selected investments from their portfolio of 67 companies
P
PanGenetics
Other · , 0
X
Xention
Other · , 0
A
Achilles Therapeutics
Other · , 0
a
arGEN-X
Other · , 0
C
Curetis
Other · , 0
A
ACADIA Pharmaceuticals
Other · , 0
A
Allecra Therapeutics
Other · , 0
P
Promedior
Other · , 0
T
Transave
Other · , 0
A
Argos Therapeutics
Other · , 0
e
enGene
Other · , 0
P
Prexton Therapeutics
Other · , 0
Frequently Asked Questions
Rogier Rooswinkel focuses on Seed stage investments.